Low-dose aspirin use and survival in breast cancer patients: A nationwide cohort study

Gay, 2011, Platelets alter tumor cell attributes to propel metastasis: programming in transit, Cancer Cell., 20, 553, 10.1016/j.ccr.2011.11.001 Simmons, 2004, Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition, Pharmacol. Rev., 56, 387, 10.1124/pr.56.3.3 Bambace, 2011, The platelet contribution to cancer progression, J. Thromb. Haemost., 9, 237, 10.1111/j.1538-7836.2010.04131.x Lloyd Jr, 2003, Aspirin inhibits highly invasive prostate cancer cells, Int. J. Oncol., 23, 1277 Mezouar, 2015, Inhibition of platelet activation prevents the P-selectin and integrin-dependent accumulation of cancer cell microparticles and reduces tumor growth and metastasis in vivo, Int. J. Cancer, 136, 462, 10.1002/ijc.28997 Ghezzo, 2005, Salicylate inhibition of rat mammary carcinogenesis and angiogenesis in female rat compatible with misoprostol administration, Int. J. Oncol., 26, 697 Chattopadhyay, 2012, Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo, Biochem. Pharmacol., 83, 723, 10.1016/j.bcp.2011.12.019 Lal, 2013, Platelets, coagulation and fibrinolysis in breast cancer progression, Breast Cancer Res., 15, 207, 10.1186/bcr3425 Blair, 2007, NSAID use and survival after breast cancer diagnosis in post-menopausal women, Breast Cancer Res. Treat., 101, 191, 10.1007/s10549-006-9277-x Holmes, 2010, Aspirin intake and survival after Breast cancer, J. Clin. Oncol., 28, 1467, 10.1200/JCO.2009.22.7918 Fraser, 2014, Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study, Br. J. Cancer, 111, 623, 10.1038/bjc.2014.264 Tamim, 2007, Application of lag-time into exposure definitions to control for protopathic bias, Pharmacoepidemiol. Drug Saf., 16, 250, 10.1002/pds.1360 Kwan, 2012, NSAIDs and breast cancer recurrence in a prospective cohort study, Cancer Causes Control, 18, 613, 10.1007/s10552-007-9003-y Wernli, 2011, Use of antidepressants and NSAIDs in relation to mortality in long-term breast cancer survivors, Pharmacoepidemiol. Drug Saf., 20, 131, 10.1002/pds.2064 Murray, 2014, Post-diagnostic prescriptions for low-dose aspirin and breast cancer-specific survival: a nested case-control study in a breast cancer cohort from the UK clinical practice, Breast Cancer Res., 16, R34, 10.1186/bcr3638 Holmes, 2014, Aspirin intake and breast cancer survival – a nation-wide study using prospectively recorded data in Sweden, BMC Cancer, 14, 391, 10.1186/1471-2407-14-391 Barron, 2015, De novo post-diagnosis aspirin use and mortality in women with stage I-III Breast cancer, Cancer Epidemiol. Biomark. Prev., 24, 898, 10.1158/1055-9965.EPI-14-1415 Rothwell, 2012, Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials, Lancet, 379, 1591, 10.1016/S0140-6736(12)60209-8 Alvarez-Madrazo, 2016, Data resource profile: the scottish national prescribing information system (PIS), Int. J. Epidemiol., 45, 714f, 10.1093/ije/dyw060 Joint Formulary Committee, British National Formulary (2014) BMJ Publishing Group Ltd. Levesque, 2010, Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes, BMJ, 340, b5087, 10.1136/bmj.b5087 Chubak, 2013, Threats to validity of nonrandomized studies of postdiagnosis exposures on cancer recurrence and survival, J. Natl. Cancer Inst., 105, 1456, 10.1093/jnci/djt211 Edge, 2010 Sundararajan, 2004, New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality, J. Clin. Epidemiol., 57, 1288, 10.1016/j.jclinepi.2004.03.012 Donnelly, 2009 Ahern, 2011, Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study, J. Natl. Cancer Inst., 103, 1461, 10.1093/jnci/djr291 Murtola, 2014, Statin use and breast cancer survival: a nationwide cohort study from Finland, PLoS One, 9, e110231, 10.1371/journal.pone.0110231 Cardwell, 2015, Statin use after diagnosis of breast cancer and survival: a population-based cohort study, Epidemiology, 26, 68, 10.1097/EDE.0000000000000189 Zhou, 2005, Survival bias associated with time-to-treatment initiation in drug effectiveness evaluation: a comparison of methods, Am. J. Epidemiol., 162, 1016, 10.1093/aje/kwi307 Weinberg, 1993, Toward a clearer definition of confounding, Am. J. Epidemiol., 137, 1, 10.1093/oxfordjournals.aje.a116591 Schisterman, 2009, Overadjustment bias and unnecessary adjustment in epidemiologic studies, Epidemiology, 20, 488, 10.1097/EDE.0b013e3181a819a1 Paulose-Ram, 2005, Frequent monthly use of selected non-prescription and prescription non-narcotic analgesics among U.S. adults, Pharmacoepidemiol. Drug Saf., 14, 257, 10.1002/pds.983 Barron, 2014, Recent prediagnostic aspirin use, lymph node involvement, and 5-year mortality in women with stage I-III breast cancer: a nationwide population-based cohort study, Breast Cancer Res. Treat., 74, 4065 Allott, 2014, Non-steroidal anti-inflammatory drug use, hormone receptor status, and breast cancer-specific mortality in the Carolina breast cancer study, Breast Cancer Res. Treat., 147, 415, 10.1007/s10549-014-3099-z Hudson, 2008, Nonsteroidal anti-inflammatory drug use and serum total estradiol in postmenopausal women, Cancer Epidemiol. Biomark. Prev., 17, 680, 10.1158/1055-9965.EPI-07-2739 Davies, 2002, Cyclooxygenase-2 (COX-2), aromatase and breast cancer: a possible role for COX-2 inhibitors in breast cancer chemoprevention, Ann. Oncol., 13, 669, 10.1093/annonc/mdf125 Yang, 2008, Chronic statin therapy and the risk of colorectal cancer, Pharmacoepidemiol. Drug Saf., 17, 869, 10.1002/pds.1599 Morant, 2003, Cardiovascular prophylaxis with aspirin: costs of supply and management of upper gastrointestinal and renal toxicity, Br. J. Clin. Pharmacol., 57, 188, 10.1046/j.1365-2125.2003.01979.x Sarfati, 2010, Measuring cancer survival in populations: relative survival vs cancer-specific survival, Int. J. Epidemiol., 39, 598, 10.1093/ije/dyp392 Langley, 2013, Evidence for the use of aspirin as a treatment for cancer and the planned Add-Aspirin trial